Javier M. Olaya-Zamora - Publications

Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: February 27, 2025

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma.

Journal: Journal of translational medicine

Published: September 12, 2024

Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation.

Journal: Clinical transplantation

Published: February 18, 2024

Changes in the Liver Transplant Waiting List after Expanding to the 'Up-to-Seven' Criteria for Hepatocellular Carcinoma.

Journal: Journal of personalized medicine

Published: October 28, 2023

Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Journal: International journal of molecular sciences

Published: December 20, 2022

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 10, 2021

Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.

Journal: International journal of molecular sciences

Published: October 29, 2021

Malignancy of intraductal papillary neoplasm of the bile duct.

Journal: Revista espanola de enfermedades digestivas

Published: August 24, 2021